LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 67.10 | 771.67 | 10273 | 9800 | 1.0482 | 1.0259 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 67.10 | 771.67 | 9479 | 9800 | 0.9672 | 0.9819 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.32 | 771.67 | 10685 | 10212 | 1.0463 | 1.0244 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 69.32 | 771.67 | 10012 | 10212 | 0.9804 | 0.9894 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.54 | 771.67 | 11031 | 10532 | 1.0473 | 1.0247 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 71.54 | 771.67 | 10433 | 10532 | 0.9905 | 0.9950 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.76 | 771.67 | 11301 | 10851 | 1.0414 | 1.0214 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 73.76 | 771.67 | 10832 | 10851 | 0.9982 | 0.9990 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.02 | 771.67 | 11617 | 11106 | 1.0459 | 1.0235 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 76.02 | 771.67 | 11179 | 11106 | 1.0065 | 1.0034 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.25 | 771.67 | 11970 | 11367 | 1.0530 | 1.0268 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 78.25 | 771.67 | 11470 | 11367 | 1.0090 | 1.0046 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.48 | 771.67 | 12302 | 11685 | 1.0528 | 1.0264 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 80.48 | 771.67 | 11809 | 11685 | 1.0106 | 1.0054 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.69 | 771.67 | 12690 | 11974 | 1.0598 | 1.0296 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.69 | 771.67 | 12255 | 11974 | 1.0235 | 1.0118 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 84.92 | 771.67 | 12910 | 12266 | 1.0524 | 1.0258 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 84.92 | 771.67 | 12639 | 12266 | 1.0303 | 1.0150 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.14 | 771.67 | 13295 | 12592 | 1.0558 | 1.0271 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.14 | 771.67 | 13070 | 12592 | 1.0379 | 1.0186 | MN20160304_L01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 2.49 | 771.67 | 845 | 867 | 0.9738 | 0.7095 | MN20160304_L01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 2.49 | 771.67 | 837 | 867 | 0.9646 | 0.6161 | MN20160304_L01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 4.71 | 771.67 | 930 | 956 | 0.9724 | 0.8273 | MN20160304_L01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 4.71 | 771.67 | 947 | 956 | 0.9902 | 0.9374 | MN20160304_L01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 6.94 | 771.67 | 1015 | 1045 | 0.9712 | 0.8707 | MN20160304_L01 | F04 |